Home
>
National Drug Code (NDC)
>
TAPAZOLE
TAPAZOLE - 60793-104-01 - (methimazole)
Drug Information of TAPAZOLE
| Product NDC: | 60793-104 |
| Proprietary Name: | TAPAZOLE |
| Non Proprietary Name: | methimazole |
| Active Ingredient(s): | 5 mg/1 & nbsp; methimazole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TAPAZOLE
| Product NDC: | 60793-104 |
| Labeler Name: | King Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040320 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000331 |
Package Information of TAPAZOLE
| Package NDC: | 60793-104-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (60793-104-01) |
NDC Information of TAPAZOLE
| NDC Code | 60793-104-01 |
| Proprietary Name | TAPAZOLE |
| Package Description | 100 TABLET in 1 BOTTLE (60793-104-01) |
| Product NDC | 60793-104 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | methimazole |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20000331 |
| Marketing Category Name | ANDA |
| Labeler Name | King Pharmaceuticals, Inc. |
| Substance Name | METHIMAZOLE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA] |
